Augusta, GA
Augusta factory to produce key component for drugs to fight malaria
Augusta’S Priciest Homes Hit The Market
Augusta’s top five luxury listings on Realtor.com, starting at $985, 000.
- An Augusta biomanufacturer is building a new facility to produce a key ingredient for malaria treatments.
- The chemical, artemisinin, is a vital component in drugs used to combat the deadly mosquito-borne illness.
- The company, Manus, is also partnering with the University of Georgia on a biomanufacturing apprenticeship program.
An Augusta biomanufacturer will start making ammunition in the global fight against malaria.
Manus last week broke ground at its local plant on Lovers Lane on a production facility to produce artemisinin. The chemical is a key starting component in drug treatments to treat the deadly mosquito-borne illness. Malaria killed more than 600,000 people worldwide in 2024, according to the World Health Organization
“This groundbreaking reflects a shift from dependence to capability,” said Ajikumar Parayil, Manus’ founder and CEO. “For decades, the U.S. has relied heavily on overseas supply chains for the building blocks of essential medicines. What we’re establishing in Augusta is a new model – one that restores control, strengthens resilience, and proves that advanced biomanufacturing can be deployed at scale, here at home.”
About 80% of key ingredients for essential U.S. medicines are made or sourced overseas, according to the U.S. Food and Drug Administration.
That has led companies such as Manus to pursue biomanufacturing production models capable of making medical compounds domestically, efficiently and on a large scale.
Earlier in 2026, Manus won federal funding to expand production to make shikimic acid, a key compound in the antiviral medication oseltamivir, better known by its brand name Tamiflu.
On April 30, Manus announced a partnership with the University of Georgia to start a structured biomanufacturing apprenticeship program in Augusta. With a UGA “academic blueprint,” according to Manus, apprentices would receive extensive training on live production equipment to produce more experienced professionals for bio-industrial manufacturers nationwide.
Manus reopened Augusta’s old NutraSweet plant in 2019. In 2021, it introduced NutraSweet Natural, a zero-calorie stevia sweetener made using a smaller environmental footprint.